Pfizer Inc. Equity-NMS: PFE

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$27.1
Open :	$27.16
Today's high :	$27.67
Today's low :	$27.09
52W low :	$19.5042
52W high :	$27.94
1Y :	2.94%
5Y :	-19.63%
EPS(TTM): :	1.36
Shares O/S :	5.69 B
Market cap :	157.21 B

What is the share price of Pfizer Inc. today?

Pfizer Inc. (PFE) share price as of February 28, 2026, is $27.65. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Pfizer Inc.?

Yes, Indian Investors can invest in the Pfizer Inc. (PFE) Share by opening an international trading account with Angel One.

How can I purchase Pfizer Inc. shares in India?

Purchasing Pfizer Inc. (PFE) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Pfizer Inc. (PFE) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Pfizer Inc.?

Yes, you can purchase fractional shares of Pfizer Inc. (PFE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Pfizer Inc.?

The market capitalization of Pfizer Inc. on February 28, 2026, is $157.21 B.

In which sector Pfizer Inc. belongs?

Pfizer Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in Pfizer Inc. stocks?

In order to invest in Pfizer Inc. (PFE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.